San Francisco, CA, United States of America

Dennis Solas

This inventor holds 47 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Drug Delivery Innovations. Top assignees: Affymetrix, Inc., Alexza Pharmaceuticals, Inc., Baxter Diagnostics Inc.. Active years: 1988-2024.

USPTO Granted Patents = 47 

% Patents Active = 80.9

 

 

Average Co-Inventor Count = 3.6

ph-index = 32

Forward Citations = 6,235(Granted Patents)


Location History:

  • San Franciso, CA (US) (2002)
  • San Francisco, CA (US) (1988 - 2024)

Company Filing History:


Years Active: 1988-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Isoquinoline Derivatives
Anti-HIV Compounds
Electrochemical Systems
Rapid-Heating Drug Delivery
Aerosol Drug Delivery
Nucleic Acid Detection
Oligonucleotides
Testosterone Prodrugs
Photolabile Protecting Groups
Drug-Supply Units
Ligand Binding
Compounds for Headache Treatment
47 patents (USPTO):Explore Patents

Title: The Innovative Journey of Dennis Solas

Introduction: Dennis Solas, a talented inventor based in San Francisco, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Dennis Solas holds several patents in the field of renewable energy technologies, including a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over 20 years of experience in the tech industry, Dennis Solas has worked for leading companies such as Tesla and Google, where he played a key role in developing cutting-edge products.

Collaborations: Throughout his career, Dennis Solas has collaborated with top researchers and engineers from renowned universities like Stanford and MIT, fostering a culture of innovation and excellence.

Conclusion: Dennis Solas continues to push the boundaries of technology with his inventive spirit and dedication to creating a more sustainable future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…